Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

Internal tandem duplication mutations in FLT3, known to be associated with a poor prognosis in acute myeloid leukaemia, are now shown to be a valid therapeutic target for the disease.